In the fight against cancer, immunotherapy—which aims to boost the body's natural defenses against cancer—is experiencing remarkable growth. Most of these treatments are based on CD8 T lymphocytes, ...

Zhuo, C., et al. (2025). Single-cell sequencing reveals the expansion and diversity of T cell subsets in the bone marrow ...

Peripheral blood CD4+/CD8+ t cell ratio predicts HBsAg clearance in inactive HBsAg carriers treated with peginterferon alpha Peer-Reviewed Publication ...

Immunologists at UNIGE have revealed a previously unknown anti-tumor role of CD4 T lymphocytes, marking a breakthrough that ...

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions ...

Cancer: «forgotten» cells go on the offensive. UNIGE Immunologists have discovered the yet unsuspected anti-tumour potential of CD4 T lymphocytes, an important step towards a ne ...

Immune checkpoint inhibitors have changed the future of cancer care. These powerful treatments use the body’s own immune ...

Researchers are working to launch a first-in-human clinical trial to test the approach in patients with cancer who develop ...

At first glance, some people seem to have recovered from COVID-19. They no longer test positive and can return to work or ...

The same pattern held, though somewhat less dramatically, for patients beginning treatment at CD4 counts of 50–199 cells/mm 3 and 200–349 cells/mm 3; for those with baseline CD4 counts > 350 ...

CD4 T-Cell Monitoring in HIV Management. Key Themes: Immune Reconstitution: Average CD4 count increases of approximately 200 cells in the first year of effective therapy Laboratory Variability ...